Drinks Americas 10Q 2009 Q2 Quarterly report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

R	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

	For the quarterly period ended October 31, 2008

OR

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the transition period from _______________ to ____________

Commission File Number: 33-55254-10

Drinks Americas Holdings, Ltd.

(Exact name of registrant as specified in its charter)

Delaware		87-0438825
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

372 Danbury Road
Wilton, CT		06897
(Address of principal executive offices)		(Zip Code)

(203) 762-7000

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes R No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

¨ Large accelerated filer	¨ Accelerated filer	¨ Non-accelerated filer	x Smaller reporting company
		(Do not check if smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No R

As of December 19, 2008, the number of shares outstanding of the registrant’s common stock, $0.001 par value, was ___85,652,904_.

DRINKS AMERICAS HOLDINGS, LTD

AND AFFILIATES

FORM 10-Q

FOR THE QUARTER ENDED OCTOBER 31, 2008

TABLE OF CONTENTS

Page

PART I	FINANCIAL INFORMATION

Item 1.	Financial Statements (Unaudited)

	Consolidated Balance Sheets	1
	Consolidated Statements of Operations	2
	Consolidated Statements of Cash Flows	3
	Notes to Consolidated Statements	4

Item 2.	Management Discussion and Analysis of Financial Condition And Results of Operations	13

Item 3.	Quantitative and Qualitative Disclosure About Market Risk	18

Item 4	Controls and Procedures	18

PART II	OTHER INFORMATION

Item 1.	Legal Proceedings	19
Item 1A.	Risk Factors	19
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	19
Item 3.	Defaults Upon Senior Securities	20
Item 4.	Submission of Matters to a Vote of Security Holders	20
Item 5.	Other Information	20
Item 6.	Exhibits	20

EXPLANATORY NOTE

Unless otherwise indicated or the context otherwise requires, all references in this Report on Form 10-Q to "we", "us", "our" and the “Company” are to Drinks Americas Holdings, Ltd., a Delaware corporation and formerly Gourmet Group, Inc., a Nevada corporation, and its majority owned subsidiaries Drinks Americas, Inc., Drinks Global Imports, LLC, and D.T. Drinks, LLC, and Maxmillian Mixers, LLC, and Maxmillian Partners, LLC.

Cautionary Notice Regarding Forward Looking Statements

The disclosure and analysis in this Report contains some forward-looking statements. Certain of the matters discussed concerning our operations, cash flows, financial position, economic performance and financial condition, in particular, future sales, product demand, competition and the effect of economic conditions include forward-looking statements within the meaning of section 27A of the Securities Act of 1933, referred to herein as the Securities Act, and Section 21E of the Securities Exchange Act of 1934, referred to herein as the Exchange Act.

Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates" and similar expressions, are forward-looking statements. Although we believe that these statements are based upon reasonable assumptions, including projections of orders, sales, operating margins, earnings, cash flow, research and development costs, working capital, capital expenditures, distribution channels, profitability, new products, adequacy of funds from operations and other projections, and statements expressing general optimism about future operating results, and non-historical information, they are subject to several risks and uncertainties, and therefore, we can give no assurance that these statements will be achieved.

Readers are cautioned that our forward-looking statements are not guarantees of future performance and the actual results or developments may differ materially from the expectations expressed in the forward-looking statements.

As for the forward-looking statements that relate to future financial results and other projections, actual results will be different due to the inherent uncertainty of estimates, forecasts and projections and may be better or worse than projected. Given these uncertainties, you should not place any reliance on these forward-looking statements. These forward-looking statements also represent our estimates and assumptions only as of the date that they were made. We expressly disclaim a duty to provide updates to these forward-looking statements, and the estimates and assumptions associated with them, after the date of this filing to reflect events or changes in circumstances or changes in expectations or the occurrence of anticipated events.

We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our Company's historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in Part II, "Item 1A. Risk Factors" and elsewhere in this report and in our Annual Report on Form 10-KSB for the year ended April 30, 2008, and those described from time to time in our future reports filed with the Securities and Exchange Commission. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.

PART 1 FINANCIAL INFORMATION

DRINKS AMERICAS HOLDINGS, LTD., AND AFFILIATES

CONSOLIDATED BALANCE SHEETS

	OCTOBER 31, 2008			APRIL 30, 2008
	(Unaudited)
Assets
Current assets:
Cash and equivalents	$	731,691		$	133,402
Accounts receivable, net of allowances		486,239			583,949
Inventories, net of allowance		1,292,248			1,844,412
Other current assets		347,250			445,278

Total current assets		2,857,428			3,007,041

Property and equipment, at cost less accumulated depreciation and amortization		74,698			91,307
Investment in equity investee		69,028			69,028
Intangible assets, net		704,984			735,559
Deferred loan costs, net		22,117			22,548
Other assets		513,168			644,762

	$	4,241,423		$	4,570,245


Liabilities and Shareholders' Equity(Deficiency)
Notes and loans payable	$	952,360		$	1,057,940
Loan Payable – related party		343,652			232,547
Accounts payable		2,265,531			1,866,477
Accrued Expenses		2,046,652			1,235,165

Total current liabilities		5,608,195			4,392,129

Commitments		—			—

Shareholders' equity (deficiency)
Preferred stock, $0.001 par value; 1,000,000 shares authorized; issued and outstanding 11,000 shares (redemption value $11,000,000)		11			11
Common stock, $0.001 par value; 100,000,000 authorized; issued and outstanding 85,588,669 shares and 81,188,224 shares, respectively		85,589			81,188
Additional paid-in capital		33,591,600			32,656,685
Accumulated deficit		(35,043,972	)		(32,559,768	)
		(1,366,772	)		178,116

	$	4,241,423		$	4,570,245

See accompanying notes to consolidated financial statements

DRINKS AMERICAS HOLDINGS, LTD., AND AFFILIATES

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

	Six months ended						Three months ended
	October 31,						October 31,
	2008			2007			2008			2007

Net sales	$	1,649,557		$	2,782,971		$	580,980		$	1,475,856

Cost of sales		1,270,034			1,712,434			539,090			874,968

Gross margin		379,523			1,070,537			41,890			600,888

Selling, general & administrative expenses		2,706,583			4,004,435			1,089,462			2,019,160

Loss from Operations		(2,327,060	)		(2,933,898	)		(1,047,572	)		(1,418,272	)

Other income (expense):
Interest		(157,144	)		(116,461	)		(135,847	)		(63,837	)
Other		-			-			-			349
Net Other Expense		(157,144	)		(116,461	)		(135,847	)		(63,488	)

Net Loss	$	(2,484,204	)	$	(3,050,359	)	$	(1,183,419	)	$	(1,481,760	)

Net loss per share (basic and diluted)	$	(0.03	)	$	(0.04	)	$	(0.01	)	$	(0.02	)

Weighted average number of common shares (basic and diluted)		81,501,368			79,594,596			81,814,511			79,610,909

See accompanying notes to consolidated financial statements

DRINKS AMERICAS HOLDINGS, LTD., AND AFFILIATES

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

	Six months ended October 31,
	2008			2007
Cash Flows From Operating Activities:
Net loss	$	(2,484,204	)	$	(3,050,359	)
Adjustments to reconcile net loss to net cash used
in operating activities:
Depreciation and amortization		72,614			102,005
Stock and warrants issued for services of vendors, promotions, directors and interest payments		64,390			130,741
Changes in operating assets and liabilities:
Accounts receivable		97,710			(31,196	)
Inventories		552,164			(127,452	)
Other current assets		131,361			465,933
Other assets		135,594			83,467
Accounts payable		399,054			908,113
Accrued expenses		983,319			(53,869	)

Net cash used in operating activities		(47,998	)		(1,572,617	)

Cash Flows From Financing Activities:
Proceeds from issuance of common stock		684,592			-
Proceeds from debt		123,375			480,621
Repayment of debt		(31,100	)		(16,788	)
Increase (decrease) in working capital revolver		(105,580	)		178,106
Payments for loan costs		(25,000	)		(50,000	)

Net cash provided by financing activities		646,287			591,939

Net increase (decrease) in cash and equivalents		598,289			(980,678	)

Cash and equivalents - beginning		133,402			994,768

Cash and equivalents - ending	$	731,691		$	14,090

Supplemental disclosure of non-cash investing
and financing transactions:

Increase in other current assets, other assets and additional paid in capital equal to the value of stock and warrants issued	$	37,333		$	416,250

Payment of accrued expenses with shares of common stock	$	153,000		$	29,583
Interest paid	$	31,734		$	37,506
Income taxes paid	$	-		$	-

See notes to consolidated financial statements

DRINKS AMERICAS HOLDINGS, LTD., AND AFFILIATES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

1. Basis of Presentation and Nature of Business

Basis of Presentation

On March 9, 2005 the shareholders of Drinks Americas, Inc. ("Drinks") a company engaged in the business of importing and distributing unique, premium alcoholic and non-alcoholic beverages associated with icon entertainers, sports figures, celebrities and destinations, to beverage wholesalers throughout the United States, acquired control of Drinks Americas Holdings, Ltd. ("Holdings"). Holdings was incorporated in the state of Delaware on February 14, 2005. On March 9, 2005 Holdings merged with Gourmet Group, Inc. ("Gourmet"), a publicly traded Nevada corporation, which resulted in Gourmet shareholders acquiring 1 share of Holdings' common stock in exchange for 10 shares of Gourmet's common stock. Both Holdings and Gourmet were considered "shell" corporations, as Gourmet had no operating business on the date of the share exchange, or for the previous three years. Pursuant to the June 9, 2004 Agreement and Plan of Share Exchange among Gourmet, Drinks and the Drinks' shareholders, Holdings, with approximately 4,058,000 shares of outstanding common stock, issued approximately 45,164,000 of additional shares of its common stock on March 9, 2005 (the "Acquisition Date") to the common shareholders of Drinks and to the members of its affiliate, Maxmillian Mixers, LLC ("Mixers"), in exchange for all of the outstanding Drinks' common shares and Mixers' membership units, respectively. As a result Maxmillian Partners, LLC ("Partners") a holding company which owned 99% of Drinks' outstanding common stock and approximately 55% of Mixers' outstanding membership units, became Holdings' controlling shareholder with approximately 87% of Holdings' outstanding common stock. For financial accounting purposes this business combination has been treated as a reverse acquisition, or a recapitalization of Partners' subsidiaries (Drinks and Mixers).

Subsequent to the Acquisition Date, Partners, which was organized as a Delaware limited liability company on January 1, 2002 and incorporated Drinks in Delaware on September 24, 2002, transferred all its shares of holdings to its members as part of a plan of liquidation.

On March 11, 2005 Holdings and an individual organized Drinks Global, LLC ("DGI"). Holdings own 90% of the membership units and the individual, who is the president of DGI, owns 10%. DGI's business is to import wines from various parts of the world and sell them to distributors throughout the United States. In May 2006 Holdings organized D.T. Drinks, LLC ("DT Drinks") a New York limited liability company for the purpose of selling certain alcoholic beverages.

The accompanying consolidated balance sheets as of October 31, 2008 and April 30, 2008 and the consolidated results of operations and consolidated cash flows for the six months ended October 31, 2008 and 2007 and the consolidated results of operations for the three months ended October 31, 2008 and 2007 reflect Holdings its majority-owned subsidiaries and Partners (collectively, the "Company"). All intercompany transactions and balances in these financial statements have been eliminated in consolidation. The amount of common and preferred shares authorized, issued and outstanding as of October 31, 2008 and April 30, 2008 are those of Holdings.

The accompanying consolidated financial statements have been prepared on a basis that assumes the Company will continue as a going concern. As of October 31, 2008 the Company has a shareholders' deficiency of $1,366 772 and we has incurred significant operating losses and negative cash flows since inception. For the six months ended October 31, 2008, the Company sustained a net loss of $2,484,204, and used $47,998 in operating activities. We have increased our working capital as a result of our October 2008 warrant repricing. In addition we have improved our liquidity by extinguishing a significant amount of debt by exchanging it for our common stock in previous periods. We will need additional financing which may take the form of equity or debt. We anticipate that increased sales revenues will help to some extent. In the event we are not able to increase our working capital, we will not be able to implement or may be required to delay all or part of our business plan, and our ability to attain profitable operations, generate positive cash flows from operating and investing activities and materially expand the business will be materially adversely affected. The accompanying financial statements do not include any adjustments relating to the classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the company be unable to continue in existence.

In the opinion of management, the accompanying unaudited consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, necessary to present fairly the financial position of the Company as of October 31, 2008 and April 30, 2008, its results of operations for the six and three months ended October 31, 2008 and 2007 and its cash flows for the six months ended October 31, 2008 and 2007. Pursuant to the rules and regulations of the SEC for the interim financial statement, certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted from these financial statements unless significant changes have taken place since the end of the most recent fiscal year. Accordingly, these financial statements should be read in conjunction with the audited consolidated financial statements and the other information in the Form 10-KSB.

Nature of Business

Through our majority-owned subsidiaries, Drinks, DGI and DT Drinks, we import, distribute and market unique premium wine and spirits and alcoholic beverages associated with icon entertainers, celebrities and destinations, to beverage wholesalers throughout the United States.

2. Critical Accounting Policies and Estimates

Significant Accounting Policies

We believe the following significant accounting policies, among others, may be impacted significantly by judgment, assumptions and estimates used in the preparation of the consolidated financial statements:

Revenue Recognition

The Company recognizes revenues when title passes to the customer, which is generally when products are shipped.

The Company recognizes revenue dilution from items such as product returns, inventory credits, discounts and other allowances in the period that such items are first expected to occur. The Company does not offer its clients the opportunity to return products for any reason other than manufacturing defects. In addition, the Company does not offer incentives to its customers to either acquire more products or maintain higher inventory levels of products than they would in ordinary course of business. The Company assesses levels of inventory maintained by its customers through communications with them. Furthermore, it is the Company's policy to accrue for material post shipment obligations and customer incentives in the period the related revenue is recognized.

Accounts Receivable

Accounts receivable are recorded at original invoice amount less an allowance for uncollectible accounts that management believes will be adequate to absorb estimated losses on existing balances. Management estimates the allowance based on collectability of accounts receivable and prior bad debt experience. Accounts receivable balances are written off upon management's determination that such accounts are uncollectible. Recoveries of accounts receivable previously written off are recorded when received. Management believes that credit risks on accounts receivable will not be material to the financial position of the Company or results of operations at October 31, 2008 and April 30, 2008 the allowance for doubtful accounts was $36,000 and $24,000, respectively.

Stock Based Compensation

The Company accounts for stock-based compensation in accordance with Statement of Financial Accounting Standard 123 (revised 2004), Share-Based Payment (SFAS 123R) using the modified prospective approach. The Company recognizes in the statement of operations the grant-date fair value of stock options and other equity based compensation issued to employees and non employees.

Earnings Per Share

The Company computes earnings per share under the provisions of SFAS No. 128, Earnings per Share, whereby basic earnings per share is computed by dividing net income (loss) attributable to all classes of common shareholders by the weighted average number of shares of all classes of common stock outstanding during the applicable period. Diluted earnings per share is determined in the same manner as basic earnings per share except that the number of shares is increased to assume exercise of potentially dilutive and contingently issuable shares using the treasury stock method, unless the effect of such increase would be anti-dilutive. For the six and three months ended October 31, 2008 and 2007, the diluted earnings per share amounts equal basic earnings per share because the Company had net losses and the impact of the assumed exercise of contingently issuable shares would have been anti-dilutive.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Actual results could differ from those estimates.

Recent accounting pronouncements

In June 2008, the FASB issued FASB Staff Position No. EITF 03-6-1, "Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities," which classifies unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents (whether paid or unpaid) as participating securities and requires them to be included in the computation of earnings per share pursuant to the two-class method described in SFAS No. 128, "Earnings per Share.” This Staff Position is effective for financial statements issued for fiscal years beginning after December 15, 2008, and interim periods within those years. All prior-period earnings per share data presented are to be adjusted retrospectively (including interim financial statements, summaries of earnings, and selected financial data) to conform to the provisions of this Staff Position, with early application not permitted. The adoption of this Staff Position, which will require us to allocate a portion of net income to these participating securities, will not have an effect on our historical reported earnings due to their anti-dilutive effect as a result of losses in all prior periods previously presented and will not have a material effect on our future reported earnings per share.

In December 2007, the FASB issued proposed FASB Staff Position (FSP) 157-b, “Effective Date of FASB Statement No. 157,” that would permit a one-year deferral in applying the measurement provisions of Statement No. 157 to non-financial assets and non-financial liabilities (non-financial items) that are not recognized or disclosed at fair value in an entity’s financial statements on a recurring basis (at least annually). Therefore, if the change in fair value of a non-financial item is not required to be recognized or disclosed in the financial statements on an annual basis or more frequently, the effective date of application of Statement 157 to that item is deferred until fiscal years beginning after November 15, 2008 and interim periods within those fiscal years. This deferral does not apply, however, to an entity that applies Statement 157 in interim or annual financial statements before proposed FSP 157-b is finalized. The Company is currently evaluating the impact, if any, that the adoption of 157-b will have on the Company’s operating income or net earnings.

On December 4, 2007, the FASB issued SFAS No. 141(R), “Business Combinations,” and SFAS No. 160, “Accounting and Reporting of Noncontrolling Interests in Consolidated Financial Statements, an amendment of ARB No. 51.” Statement No. 141(R) is required to be adopted concurrently with Statement No. 160 and is effective for business combination transactions for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008. Early adoption is prohibited. Application of Statement No. 141(R) and Statement No. 160 is required to be adopted prospectively, except for certain provisions of Statement No. 160, which are required to be adopted retrospectively. Business combination transactions accounted for before adoption of Statement No. 141(R) should be accounted for in accordance with Statement No. 141 and that accounting previously completed under Statement No. 141 should not be modified as of or after the date of adoption of Statement No. 141(R). The Company is currently evaluating the impact of Statement No. 141(R) and Statement No. 160, but does not expect the adoption of these pronouncements to have a material impact on the Company’s financial position or results of operations.

In February 2007, the FASB issued Statement of Financial Accounting Standards (SFAS) No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities” (SFAS 159), which allows an entity the irrevocable option to elect fair value for the initial and subsequent measurement for certain financial assets and liabilities on a contract-by-contract basis. Subsequent changes in fair value of these financial assets and liabilities would be recognized in earnings when they occur. SFAS 159 further establishes certain additional disclosure requirements. SFAS 159 is effective for fiscal years beginning after November 15, 2007, with earlier adoption permitted. The adoption of this pronouncement did not have a material impact on the Company’s consolidated financial position or results of operations.

3. Inventories

As of October 31, 2008 and April 30, 2008, Inventories consist of the following:

	2008
	October 31		April 30

Finished goods	$	551,857	$	1,012,656
Raw materials		740,391		831,756
	$	1,292,248	$	1,844,412

In October 2008 the Company recorded an allowance for slow moving inventory of $106,000. This allowance was recorded on finished goods, primarily on its Cohete Rum, of which the Company has sold at below cost subsequent to October 31, 2008

4. Other current assets

As of October 31, 2008 and April 30, 2008 Other Current Assets consisted of the following:

	2008
	October 31		April 30
Prepaid inventory purchases	$	284,960	$	405,451
Prepaid insurance		-		14,994
Other		62,290		24,833
	$	347,250	$	445,278

5. Other Long-term Assets

In August 2006, in connection with an agreement with one of its sales consultants the Company issued warrants to purchase 100,000 shares of Holdings common stock at an exercise price of $0.60 per share. The warrants may be exercised at any time up to five years from the date of the agreement. The Company determined, as of the grant date of the warrants, that the warrants had a value of $18,000 which was amortized over the one year benefit period of such warrants. In addition, under the terms of the agreement, the consultant received 175,000 shares of Holdings common stock which were valued at $107,000 based on the market price of the stock at the date of the agreement. The value of stock issued is being amortized over the five year life of the consulting agreement. The consultant is to receive an additional 100,000 warrants for each contract year with an exercise price to be determined by the Company’s board of directors. On August 28, 2008, the Company agreed to issue the consultant warrants to purchase an additional 200,000 shares of the Company’s common stock at an exercise price of $0.50 per share. This issuance satisfies the Company’s requirements for the contract years ending August 2007 and 2008. Management has determined that the aggregate value of the warrants was $4,000 based on a market price of $0.28 per share of the Company stock on the date of grant. The warrants expire five years from the date of grant.. The unamortized value of the stock and warrants at October 31, 2008 and April 30, 2008 was $57,973 and $68,948, respectively Also, on August 28, 2008 the consultant and the Company agreed to convert $153,000 of past due consulting fees into 306,000 shares of common stock at $0.50 per share which was at a premium to the market price on date of grant.

In February 2007, the Company entered into a five year agreement with a consulting company to provide certain financial advisory services. The Company prepaid $300,000 for such services. This amount is carried as a long-term asset and is being amortized over the five year life of the agreement. At October 31, 2008 and April 30, 2008 the unamortized balance of the agreement was $195,123and $210,647, respectively. On August 21, 2008 the Company agreed to issue the principals of the consulting company warrants to purchase 500,000 shares of the Company’s common stock at an exercise price of $0.50 per share. The warrants were issued to the principals for their role in the Company securing a strategic relationship. The warrants expire five years from the date of grant. Management has determined that the aggregate value of the warrants was $7,000 based on a market price of $0.26 per share of the Company stock on the date of grant

0n June 14, 2007, in connection with an endorsement agreement, the Company issued warrants to purchase 801,000 shares of the Company’s common stock at a price of $1.284 per share. The warrants may be exercised at any time up to June 14, 2017. The Company determined that the warrants had a value of $416,500, as of the date the warrants were granted, which is being amortized over the three year term of the endorsement agreement. The warrants have cashless exercise provisions. At October 31, 2008 and April 30, 2008, the unamortized balance was $224,661 and $ 304,034, respectively. The Company has also, as partial consideration for monthly consulting services, agreed to issue to a principal of one of the entities involved in the endorsement agreement, warrants to purchase 3,000 shares of the Company’s common stock per month at the monthly average market price. As of October 31, 2008 warrants to purchase 72,000 shares of the Company’s stock have been earned under this agreement of which a warrant for 54,000 shares has been issued at exercise prices ranging from $0.19 to $2.12 per share of common stock. The aggregate value, which are accounted for as consulting expenses, of the 72,000 warrants earned aggregate $12,150. Each warrant issuance has an exercise period of 5 years.

6. Notes and Loans Payable

Notes and loans payable consist of the following at October 31, 2008 and April 30, 2008:

	2008
	October 31		April 30
Due to RBCI(a)	$	500,000	$	500,000
Convertible note(b)		250,000		250,000
Revolving finance facility(c)		202,360		307,940
		952,360		1,057,940
Less current portion		952,360		1,057,940

Long-term portion	$	—	$	—

(a)

On October 27, 2005, the Company acquired certain assets of Rheingold Beer (“Rheingold”) and assumed certain obligations from Rheingold Brewing Company, Inc. (“RBCI”). Holdings issued 724,638 shares of common stock with a fair value of approximately $650,000 to RBCI and assumed approximately $142,000 of their liabilities and are contractually obligated to RBCI to issue an additional $500,000; payable in Holdings common stock with a value of $350,000 and $150,000 cash, accruing no interest. The obligation due RBCI was originally due on October 27, 2006. Due to nonpayment of the balance as a result of disagreements over certain of the acquired assets and liabilities, the Company was sued by RBCI (see Note 13).

(b)

In October 2006, the Company borrowed $250,000 and issued a convertible promissory note in like amount. The due date of the loan was extended by the Company to October 2008 from October 2007 in accordance with the terms of the original note agreement. The Company is currently engaged in a negotiation with the lender to modify certain terms of his agreement, including, without limitation, deferral of payment of principal and accrued interest. The note is convertible into shares of our common stock at $0.60 per share. The note bears interest at 12% per annum and is payable quarterly. At the option of the lender, interest can be paid in shares of Company common stock. During the year ended April 30, 2008 the Company issued the note holder an aggregate of 49,307 shares of Holdings common stock to satisfy an aggregate of $29,583 of unpaid interest accrued through October 10, 2007. In February 2008 the Company paid the note holder an additional $7,742 for interest accrued through January 10, 2008. At October 31, 2008 and April 30, 2008 accrued interest on this loan aggregated $24,693 and $9,283, respectively, which is included in accrued expenses on the accompanying balance sheets. In connection with this borrowing we issued warrants to purchase 250,000 shares of our common stock for $0.60 per share. These warrants are exercisable for a five-year period from the date of issuance. The Company had determined, as of the date the notes were issued, the warrants had a value of $48,000 which is being expensed over the life of the related debt. The terms of the note enables the holder to convert such security into common stock of the Company at a price of $0.60 per share, which was at a discount to the market price of the common stock at the date convertible. At issuance, the convertible note was convertible into shares of the Company's common stock with an aggregate value which exceeded the amount of proceeds allocated to the convertible note by $58,000.

(c)

In June 2006, the Company entered into a $10 million, three year, working capital revolving finance facility with BACC, a division of Sovereign Bank. Interest on the line of credit is prime rate plus 1.5 At October 31, 2008 and April 30, 2008 interest was 5.50% and 6.50%, respectively. The facility is secured by a first security interest in the assets of the Company (other than those of DT Drinks which is subordinated to Gateway Trade Finance, LLC (“Gateway”) (formerly Production Finance International, LLC). At October 31, 2008 and April 30, 2008, $202,360 and $307,940, respectively, was outstanding on this facility. In December 2008 the Company was notified by the lender, BACC, that the lender has calculated interest on the working capital line incorrectly since the inception of the line in June 2006. Although the Company intends to vigorously contest the amount we have accrued $100,000 of interest for the six months ended October 31, 2008 which is the approximate amount of the indicated “shortfall”. BACC has agreed to defer payment of the “back” interest beginning February 2009 payable over a 5 month period. The Company is currently engaged in a negotiation with BACC to modify certain terms of its agreement, including, without limitation, the aggregate amount of availability under the line and the terms under which interest is calculated.

7. Accrued expenses consist of the following at October 31, 2008 and April 30, 2008:

	2008
	October 31		April 30
Payroll, board compensation,
and consulting fees owed to
officers, directors and shareholders	$	1,140,065	$	742,567
All other payroll and consulting fees		292,693		218,413
Interest		136,748		11,339
Others		477,146		262,846
	$	2,046,652	$	1,235,165

8. Shareholders' Equity

Issuances of the Company’s common stock for the 6 months ended October 31, 2008, in addition to issuance disclosed to in Note 5 were as follows:

On October 27, 2008, in order to encourage holders of warrants which we issued in our January Financing (described below) to exercise their warrants, and enabling us to decrease the number of unexercised warrants and raise short-term working capital at low cost, the Company reduced the exercise price from $.50 to $0.20 per share of common stock for a period of 5 trading days, subject to adjustment in the event that the Company’s stock trades for $1.50 or higher (subject to adjustments for forward and reverse stock splits, recapitalizations, stock dividends, and the like after the date hereof) for ten (10) consecutive trading days through February 28, 2009 then the exercise price reverts to the exercise price of $.50 per share and the warrant holders must pay the Company the difference of $.30 per share, as part of this re-pricing program. Each of the investors who participated in the January Financing exercised all of the warrants issued in the private placement representing a total of 3,777,778 newly issued shares of common stock, resulting in proceeds to the Company of $755,556 less a due diligence fee paid of $70,693. We also agreed to reduce the conversion price of the preferred stock acquired by these investors in our December Financing ( described below ) from $0.50 per share of common stock to $0.35 per share. There are a total of 11,000 shares of preferred shares outstanding with a redemption value of $11,000,000 which if all the preferred stock was converted would result in the issuance of 31,428,571 shares of our common stock. One other investor, Greenwich Beverage Group LLC, who is controlled by a member of our board of directors, elected to exercise warrants for a total of 166,667 shares of common stock at $0.20 per share, which the Company reduced from $1.25, for an aggregate exercise price of $33,333 which amount is included in other current assets on the accompanying balance sheet as of October 31, 2008.

As of October 31, 2008, warrants to purchase 6,336,0980 shares of Holdings common stock were outstanding, in addition to warrants previously disclosed in Note 5 they are as follows:

In September 2008 as a bonus for work performed the Company granted its Chief Financial Officer warrants to purchase 300,000 shares of its common stock at an exercise price of $.50 per share. The warrants expire five years from the date of the agreement. Management has determined that the aggregate value of the warrants was $4,200 based on the market price of $0.26 per share of the Company’s common stock on the date of grant.

In July 2008 in connection with an extension of a licensing agreement for one of our brands the Company issued 100,000 shares of common stock and warrants to purchase an additional 300,000 shares of common stock to a charitable organization supported by one of the icons with whom we have a relationship. Company management has determined the value of such shares at the date of grant was $25,000. Under the terms of the warrant agreement 100,000 shares of common stock are exercisable September 1, 2009, 100,000 shares of common stock are exercisable September 1, 2010, and 100,000 shares of common stock are exercisable September 1, 2011. The exercise price of the warrants is $0.50 per share. The warrants expire five years from the date they are first exercisable. Management has determined that the aggregate value of the warrants was $3,000 based on the market price of $0.25 per share of the Company’s common stock on the date of grant.

In June 2008, 50,000 shares of our common stock and warrants to purchase an additional 150,000 shares or shares of our common stock were issued to one of the Company’s vendors as part of an agreement to sell their brand. The aggregate market value of the stock issued was $12,500 based on the market price on the date of grant. The exercise price of the warrants is $0.50 per share. The warrants expire five years from the date of the agreement. Management has determined that the aggregate value of the warrants was $1,700 based on the market price of $0.25 per share of the Company’s common stock on the date of grant.

On December 18, 2007 (the "Closing Date") the Company sold to three related investors (the "December Investors") an aggregate of 3,000 shares of our Series A Preferred Stock, $.001 par value (the "Preferred Stock"), at a cash purchase price of $1,000 per share, generating gross proceeds of $3,000,000 (the “December Financing”). The Preferred Stock has no voting or dividend rights. Out of the gross proceeds of the December Financing, we paid Midtown Partners & Co., LLC (the "Placement Agent") $180,000 in commissions and $30,000 for non-accountable expenses. We also issued, to the Placement Agent, warrants to acquire 600,000 shares of our Common Stock for a purchase price of $.50 per share (the "Placement Agent Warrants"), which warrants are exercisable for a five year period and contain anti-dilution provisions in the events of stock splits and similar matters. Both the commissions and expenses were accounted for as a reduction of Additional Paid in Capital.

The financing that we consummated in January 2007 (the “January Financing”) provided participating investors (the “January Investors”) rights to exchange the common stock they acquired for securities issued in subsequent financings which were consummated at a common stock equivalent of $2.00 per share or less. Under this provision, the January Investors have exchanged 4,444,445 shares of common stock for 8,000 shares of Preferred Stock. The 4,444,445 shares returned were accounted for as a reduction of Additional Paid in Capital and a reduction of Common Stock since the shares have been cancelled. Also in the January Financing, the January Investors acquired warrants to purchase 3,777,778 shares of our common stock at an exercise price of $3.00 per share (the “January Warrants”). These warrants were exercised at $.20 per share of common stock. In total we have issued $11,000,000 of our Series A Preferred Stock, which under their original terms were convertible into our Common Stock at $0.50 per share, are now convertible at $0.35 under the provisions of our Warrant Repricing Program.

Each of our December Investors participated in the January Financing but not all of our January Investors participated in the December Financing.

We do not have sufficient shares of common stock available to allow for the conversion of all of the preferred stock into common stock. We have agreed, and our board of directors previously approved amending our Certificate of Incorporation to increase the number of shares of common stock we are authorized to issue to 500,000,000 shares. Approval of our stockholders shall be required to effect such amendment under Delaware law and we have scheduled our annual meeting of our stockholders for the purpose of securing such approval.

In October and November 2006, the Company sold 1,750,000 shares of its common stock for $1,050,000 to investors. Greenwich Beverage Group, LLC (“Greenwich”), an entity controlled by a member of our board of directors acquired 333,333 shares of common stock for $200,000. In addition, these investors were issued warrants, exercisable for five years from the date of the investment, to purchase 875,000 (Greenwich was issued 166,667 of these) shares of common stock at a price of $1.25 per share. The Company has the option to redeem up to 50% of the warrants at anytime prior to exercise at a price of $0.50 per warrant. In October 2008, Greenwich elected to exercise their warrants at $0.20 per share, with the Company receiving $33,333 in proceeds.

In October 2006, as disclosed in Note 6 to the financial statements, in connection with borrowings of $250,000 in exchange for a convertible note, the Company issued warrants to purchase 250,000 shares of Holdings common stock, at an exercise price of $0.60 per share. The warrants expire five years from the date of the agreement.

In August 2006, as disclosed in Note 5 to the financial statements, in connection with a consulting agreement, the Company issued warrants to purchase 100,000 shares of Holdings common stock at an exercise price of $0.60 per share. The warrants expire five years from the date of the agreement.

Warrants were issued in connection with convertible notes issued in July 2006 to purchase an aggregate of 300,000 of Holding’s common stock at an exercise price of $0.50 per share. The warrants were issued in lieu of interest payments. The warrants expire five years from the date of issuance.

In February 2006, the Company issued warrants to purchase 250,000 shares of common stock at a price of $0.56 per share to a consultant in connection with consulting services rendered the Company. The warrants are exercisable through February 2011.

Warrants issued in connection with convertible notes issued between December 2005 and February 2006 to purchase an aggregate of 445,646 shares of Holding’s common stock at an exercise price of $0.45 per share. The warrants may be exercised at any time up to five years from the date of the notes. Warrants to purchase 55,556 shares are owned by Greenwich and warrants to purchase 83,333 shares are owned by a significant shareholder of the Company.

Warrants were issued in connection with senior convertible notes which were issued between March and May 2005 to purchase an aggregate of 1,350,000 shares of Holdings common stock at a per share price of $0.45. These warrants also have cashless exercise provisions. The warrants may be exercised at any time up to five years from the date of the notes. Warrants to purchase 100,000 shares are owned by Greenwich. In December 2006 three of the warrant holders exercised their warrants under the cashless exercise provisions of the warrants receiving an aggregate of 402,587 shares of the Company's common stock. Warrants to purchase an aggregate 0f 820,000 shares of the Company’s stock remain outstanding.

9. Income Taxes

No provision for taxes on income is included in the accompanying statements of operations because of the net operating losses for both the six and three months ended October 31, 2008 and 2007. Holdings and Drinks previously filed income tax returns on a June 30 and December 31 tax year, respectively; however, both companies applied for and received a change in tax year to April 30 and file a federal income tax return on a consolidated basis. The consolidated net operating loss carry forward as of October 31, 2008 is approximately $25,000,000, available to offset future years' taxable income expiring in various years through 2028.

A valuation allowance has been provided against the entire deferred tax asset due to the uncertainty of future profitability of the Company. Management's position with respect to the likelihood of recoverability of these deferred tax assets will be evaluated each reporting period.

Reconciliation of the differences between the statutory tax rate and the effective income tax rate is as follows for the three months ended October 31, 2008 and 2007:

	2008			2007
Statutory federal tax (benefit) rate		(34.00	)%		(34.00	)%
Statutory state tax (benefit) rate		(4.00	)%		(4.00	)%
Valuation allowance		38.00	%		38.00	%

Effective income tax rate		—			—

10. Related Party Transactions

Related party transactions for the six and three months ended October 31, 2008 and 2007 are as follows:

Consulting and Marketing Fees

For each of the six and three months ended October 31, 2008 and 2007, the Company incurred fees for services rendered related to sales and marketing payable to a limited liability company which was controlled by the Company's chairman of the board aggregating $42,000 and $21,000, respectively. As of October 31, 2008 and April 30, 2008 unpaid fees owed to the chairman's firm, aggregated $133,550 and $98,550, respectively.

In fiscal 2003 we entered into a consulting agreement with a company wholly owned by a member of the Company's board of directors. Under the agreement the consulting company is being compensated at a rate of $100,000 per annum. For each of the six and three months ended October 31, 2008 and 2007 the Company incurred fees to the consulting company of $50,000 and $25,000, respectively. As of October 31, 2008 and April 30, 2008 we were indebted to the consulting company in the amount of $206,248 and $156,248, respectively.

In December 2002 the Company entered into a consulting agreement with one of its shareholders which provides for $600,000 in fees payable in five fixed increments over a period of 78 months. The Company has an informal agreement with the shareholder pursuant to which he has the option of converting all or a portion of the consulting fees owed him into shares of Holding's common stock at a conversion price to be agreed upon. For each of the six three months ended October 31, 2008 and 2007 consulting fees incurred to this shareholder aggregated $60,000 and $30,000, respectively. As of October 31, 2008 and April 30, 2008 amounts owed to this shareholder aggregated $90,000 and $30,000, respectively.

For the six and three months ended October 31, 2008 the Company incurred marketing fees to a company controlled by the Company’s CEO of $12, 375 and $0, respectively. For the six and three months ended October 31, 2007 the Company did not incur fees to this company.

Legal Fees

For both the six and three months ended October 31, 2007, the Company incurred legal fees payable to a member of the Company's board of directors aggregating $21,000. The Company has not incurred fees to this director during the six months ended October 31, 2008.

Royalty Fees

In connection with the Company's distribution and licensing agreements with its equity investee the Company incurred royalty expenses for the six months ended October 31, 2008 and 2007 of approximately $18,000 and $37,000, respectively and for the three months ended October 31, 2008 and 2007 of approximately $9,000 and $25,000 These amounts are included in selling, general and administrative expenses in the accompanying consolidated statements of operations.

Loan Payable

From July 2007 through April 2008 the Company borrowed an aggregate of $522,303 from our CEO for working capital purposes. For the six months ended October 31, 2008 the Company borrowed an additional $123,375 from our CEO for working capital purposes. The borrowings bear interest at 12% per annum. As of October 31, 2008, a total of $358,654 including interest has been repaid. For the six months ended October 31, 2008 and 2007 interest accrued on this loan aggregated $18,831 and $15,648 respectively and for the three months ended October 31, 2008 and 2007, $10,334 and $13,849, respectively. As of October 31, 2008 and April 30, 2008 amounts owed to our CEO on these loans aggregated $343,652 and $232,547, respectively, including accrued interest.

11. Sales Concentration

For the six months ended October 31, 2008 and 2007 , our largest customer accounted for 13% and 11% of out nets sales, respectively and for each of the three months ended October 31, 2008 and 2007 accounted for 16% of our net sales. For the six months ended October 31, 2008 and 2007 , another customer accounted for 12% and 10% of out nets sales, respectively and for the three months ended October 31, 2008 and 2007 accounted for 18% and 12%, respectively of our net sales. For the six months ended October 31, 2008 and 2007 a third customer accounted for 13% and 6% of out nets sales, respectively and for the three months ended October 31, 2008 and 2007 accounted for 14% and 10%, respectively of our net sales. For the six and three months ended October 2008 a fourth customer accounted for 10% and 12%, respectively, of our net sales.

12. Commitments

Lease

The Company leases office space under an operating sublease, with minimum annual rentals of $50,000 through October 31, 2009. The Company leases additional office under an operating lease that requires minimal annual rental payments of $51,600 until March 2009.

Rent expense for these leases aggregated approximately $53,000 and $50,000 for the six months ended October 31, 2008 and 2007, respectively. Rent expense for these leases aggregated approximately $27,000 and $25,000 for the three months ended October 31, 2008 and 2007, respectively

Future minimum payments for all leases are approximately as follows:

Year Ending
April 30,	Amount
2009	$	46,500
2010		12,500

License Agreement

In November 2005 the Company entered into an eight-year license agreement for sales of Trump Super Premium Vodka. Under the agreement the Company is required to pay royalties on sales of the licensed product. The agreement requires minimal royalty payments through November 2012 which if not paid could result in termination of the license. The Company is currently engaged in a negotiation with Trump Marks LLC to modify certain terms of its license agreement, including, without limitation, the deferral of certain minimum aggregate royalties and the payment of on-going minimum royalties.

13. Litigation

On or about July 19, 2006, Manhattan Beer Distributor, LLC, a wholesale distributor of beverages in the State of New York, (“MBD”) initiated litigation in the Supreme Court of the State of New York in Bronx County (Index No. 17776-2006) against the Company. Plaintiff sued for approximately $87,000 plus interest, for alleged distribution services rendered both prior and subsequent to the acquisition of certain assets related to Rheingold Beer. We have answered the complaint and have filed a cross-claim against RBCI Holdings, Inc. (“RBCI”), the entity that sold us the assets, for the portion of the complaint related to pre-acquisition services. RBCI has not filed an answer. The discovery phase of the litigation has been completed. There have been continuing settlement negotiations and a trial which was originally scheduled for September 12, 2008 has been rescheduled to January 15, 2009.

In April 2007, RBCI filed a complaint against the Company in the U.S. District court, Southern District of N.Y. (No. 07-CV-02877). RBCI seeks $150,000 plus 525,738 shares of common stock of the Company and re-assignment of the Rheingold license in damages for an alleged breach of the Asset Purchase Agreement, related to the October 27, 2005 purchase of certain Rheingold assets. The Company has filed a motion to dismiss the complaint. The Company believes that RBCI overstated assets, understated liabilities and misrepresented revenue in connection with the asset sale. On November 13, 2008 the case was dismissed with leave for either side to restore to calendar subject to settlement within 30 days and the parties are discussing possible resolution of the issues.

In July 2007, Michele Berg, a former employee of the Company, initiated litigation against the Company in Superior Court of Arizona, Maricopa County (CV 2006-019515). The plaintiff seeks $8,125 of unpaid wages, $31,740 for reimbursement of expenses and other compensation, and treble damages for wage claim, for a total of $61,133. The Company is engaging in ongoing settlement discussions with the plaintiff.

In August 2008, TRN Logistics, LLC (“TRN”), a vendor of the Company, filed a complaint against the Company in the Superior Court of the State of Connecticut, Fairfield County. TRN seeks $27,170 for non-payment for transportation services it provided the Company. The Company has worked out a monthly payment plan with the vendor.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Introduction

The following discussion and analysis summarizes the significant factors affecting (1) our consolidated results of operations for the six and three months ended October 31 2008, compared to the six and three months ended October 31, 2007, and (2) our liquidity and capital resources. This discussion and analysis should be read in conjunction with the consolidated financial statements and notes included in Item 1 of this Report, and the audited consolidated financial statements and notes included in Form 10-KSB, which Report was filed on August 4, 2008.

Six Months Ended October 31, 2008 and 2007:

Net Sales: Net sales were $1,650,000 for the six months ended October 31, 2008 compared to net sales of $2,783,000 for the six months ended October 31, 2007, a decrease of 41%. The decrease is predominantly due to inventory shortfalls as a result of insufficient working capital and the resulting delay of certain shipments. Trump Super Premium Vodka sales aggregated $805,000 which accounted for 49% of total dollar sales for the six months ended October 31, 2008. For the six months ended October 31, 2007, Trump Super Premium Vodka sales aggregated $1,557,000 which accounted for 56% of total dollar sales. This represents a dollar decrease of 48%. In addition to temporary inventory shortfalls for Trump Super Premium Vodka sales of Trump for the six months ended October 31, 2008 were also effected by issues relating to our California distributor which are currently being corrected. The launch of Trump Super Premium Vodka in Texas in July 2007 also contributed to greater sales of Trump Super Premium Vodka for the six months ended October 31, 2007 compared to the six months ended October 31, 2008. Trump sales in New Jersey have increased for the six months ended October 31, 2008 compared to October 31, 2007 due to improved casino sales. Sales of all wine and spirits products aggregated $1,350,000 for the six months ended October 31, 2008 compared to $2,281,000 for the six months ended October 31, 2007. Net sales of Old Whiskey River Bourbon totaled $142,000 on 1,110 cases sold for the six months ended October 31, 2008 compared to net sales of $257,000 on 2,201 cases sold for the six months ended October 31, 2007. This represents a dollar decrease of 45% and a case decrease of 50%. Net sales of our Aguila Tequila aggregated $44,000 on 533 cases sold for the six months ended October 31, 2008 compared to $34,000 on 404 cases sold for the six months ended October 31, 2007. This represents a dollar increase of 31.0% and a case increase of 32%. Net sales of our Damiana Liqueur aggregated $109,000 on 825 cases sold for the six months ended October 31, 2008 compared to net sales of $86,000 on 689 cases sold for the six months ended October 31, 2007. This represents a dollar increase of 27% and a case increase of 20%. Net sales of our premium imported wines totaled $249,000 on 2,393 cases sold for the six months ended October 31, 008 compared to net sales of $331,000 on 2,233 cases sold for the six months ended October 31, 2007. This represents a dollar decrease of 25% and a case decrease of 7%. The percentage dollar decrease compared to case decrease was significantly greater due increased liquidation of certain closed-out wines in the current year. The Company is considering whether it should continue this product line. Net sales of our non alcoholic product, Newman’s Own sparkling fruit beverages and sparkling waters decreased to $300,000 on 34,501 cases sold for the six months ended October 31, 2008 compared to $502,000 on 55,857 cases sold for the six months ended October 31, 2007. This represents a dollar decrease of 42% and a case increase of 38%. Sales of our Newmans Own products were also affected by temporary inventory shortfalls.

Gross margin: Exclusive of our allowance for slow moving inventory, gross profit was $486,000 (29.4% of net sales) for the six months ended October 31, 2008 a decrease of $585,000, compared to gross profit of $1,071,000 (38.5% o f net sales) for the six months ended October 31, 2007. Gross margin for our wine and spirits business was 31.5% percent for the six months ended October 31, 2008 compared to 43.0% for the prior year. Gross margin for our non alcoholic business was 19.4 percent for the six months ended October 31, 2008 compared to 18.6 % for the six months ended October 31, 2007. The increase in gross margin for our Newmans’ Own products is the result of increases in our selling price. The gross profit margin of our non alcoholic Newman’s Own products is expected to further improve with the implementation of alternate packaging which will lead to lower product costs. Gross margin of our wines decreased to 13.3% for the six months ended October 31, 2008 from 30.2% for the six months ended October 31, 2007. This decrease is the direct result of the aforementioned close-out of certain wines in the current year. Gross margin of Trump Super Premium Vodka, decreased to 33.4% for the six months ended October 31, 2008 compared to 47.2% for the six months ended October 31, 2007. The gross margin decrease is largely due to a decrease in the percentage of direct sales which leads to increased direct costs such as excise taxes and freight, price competition, and a weaker dollar against the Euro which has increased Trump Vodka component costs. For the six months ended October 31, 2008 the Company recorded a reserve for Cohete Rum of $106,000 as it is the Company’s intention to liquidate the inventory and terminate the brand.

Selling, general and administrative: Selling, general and administrative expenses totaled $2,707,000 for the six months ended October 31, 2008, compared to $4,004,000 for the six months ended October 31, 2007, a decrease of $1,297,000 or 32.4%. Total selling and marketing costs aggregated $1,162,000 for the six months ended October 31, 2008 compared to $2,045,000 for the six months ended October 31, 2007. The decrease in selling and marketing expenses is due to the overall decreased marketing spend on Trump Super Premium Vodka to a normalized level as sales promotions for Trump Vodka have become more targeted. General and administrative expenses aggregated $1,545,000 for the six months ended October 31, 2008 compared to $1,959,000 for the six months ended October 31, 2007. Charges relating to purchase order financing aggregated $5,000 for the six months ended October 31, 2008 compared to $37,000 for the six months ended October 31, 2007 as the Company utilized its working capital revolving line. Professional fees, including legal fees have decreased from the prior year and travel related expenses have also decreased for the six months ended October 31, 2008 compared to the six months ended October 31, 2007.

Other Income (expense): Interest expense totaled $ 157,000 for the six months ended October 31, 2008 compared to expense of $116,000 for the six months ended October 31, 2007. In December 2008 the Company was notified by its lender, BACC, that the lender has calculated interest on the working capital line incorrectly since the inception of the line in June 2006. Although the Company is going to vigorously contest the amount we have accrued $100,000 of interest expense for the six months ended October 31, 2008 which is the approximate amount of the indicated “shortfall”.

Income Taxes: We have incurred substantial net losses from our inception and as a result, have not incurred any income tax liabilities. Our federal net operating loss carry forward is approximately $25,000,000, which we can use to reduce taxable earnings in the future. No income tax benefits were recognized in fiscal 2008 and 2007 as we have provided valuation reserves against the full amount of the future carry forward tax loss benefit. We will evaluate the reserve every reporting period and recognize the benefits when realization is reasonably assured.

Three Months Ended October 31, 2008 and 2007:

Net Sales: Net sales were $581,000 for the three months ended October 31, 2008 compared to net sales of $1,476,000 for the three months ended October 31, 2007, a decrease of 61%. The decrease is due to the aforementioned inventory shortfalls as a result of insufficient working capital and the resulting delay in certain shipments. Trump Super Premium Vodka sales aggregated $284,000 which accounted for 49% of total dollar sales for the three months ended October 31, 2008. For the three months ended October 31, 2007, Trump Super Premium Vodka sales aggregated $764,000 which accounted for 52% of total dollar sales. The decrease of 63% is predominantly due to temporary inventory shortfalls and the timing of certain shipments. Sales of all wine and spirits products aggregated $555,000 for the three months ended October 31, 2008 compared to $1,287,000 for the three months ended October 31, 2007. Net sales of Old Whiskey River Bourbon totaled $46,000 on 347 cases sold for the three months ended October 31, 2008 compared to net sales of $190,000 on 1,700 cases sold for the three months ended October 31, 2007. This represents a dollar decrease of 76% and a case decrease of 80%. Net sales of our Aguila Tequila aggregated $12,000 on 159 cases sold for the three months ended October 31, 2008 compared to $8,000 on 91 cases sold for the three months ended October 31, 2007. This represents a dollar increase of 59.0% and a case increase of 75%. Net sales of our Damiana Liqueur aggregated $35,000 on 267 cases sold for the three months ended October 31, 2008 compared to net sales of $40,000 on 322 cases sold for the three months ended October 31, 2007. This represents a dollar decrease of 12% and a case decrease of 17%. Net sales of our premium imported wines totaled $177,000 on 1,597 cases sold for the three months ended October 31, 008 compared to net sales of $269,000 on 1,582 cases sold for the three months ended October 31, 2007. This represents a dollar decrease of 34% and a case decrease of 1%. The percentage dollar decrease compared to case was significantly greater due to greater liquidation of certain closed-out wines at below cost in the current year. Net sales of our non alcoholic product, Newman’s Own sparkling fruit beverages and sparkling waters decreased to $26,000 on 5,019 cases sold for the three months ended October 31, 2008 compared to $189,000 on 23,212, cases sold for the three months ended October 31, 2007. This represents a dollar decrease of 86% and a case increase of 78%. Sales of our Newmans Own products were also affected by temporary inventory shortfalls.

Gross margin: Exclusive of our allowance for slow moving inventory, gross profit was $148,000 (25.5% of net sales) for the three months ended October 31, 2008 a decrease of $453,000, compared to gross profit of $601,000 (40.7% o f net sales) for the three months ended October 31, 2007. Gross margin for our wine and spirits business was 26.6% percent for the three months ended October 31, 2008 compared to 42.4% for the prior year. Gross margin for our non alcoholic business was 0 percent for the three months ended October 31, 2008 compared to 20.3 % for the three months ended October 31, 2007 . The decrease in gross margin for our Newmans’ Own products is the result of the selling of remaining cases at cost. Gross margin of our wines decreased to 7.2% for the three months ended October 31, 2008 from 31.6% for the three months ended October 31, 2007 due to the close out at a deep discount of the Company’s wine business. Gross margin of Trump Super Premium Vodka, decreased to 34.1% for the three months ended October 31, 2008 compared to 47.8% for the three months ended October 31, 2007. The gross margin decrease is largely due to a decrease in the percentage of direct sales which leads to increased direct costs such as excise taxes and freight and price support for Trump Super Premium Vodka necessary in order to achieve competitive pricing. For the three months ended October 31, 2008 the Company recorded a reserve for Cohete Rum of $106,000 as it is the Company’s intention to liquidate the inventory and terminate the brand.

Selling, general and administrative: Selling, general and administrative expenses totaled $1,089,000 for the three months ended October 31, 2008, compared to $2,019,000 for the three months ended October 31, 2007, a decrease of $930,000 or 46.1%. Total selling and marketing costs aggregated $409,000 for the three months ended October 31, 2008 compared to $995,000 for the three months ended October 31, 2007. The decrease in selling and marketing expenses is due to the overall decreased marketing spend on Trump Super Premium Vodka to a normalized level as sales promotions for Trump Vodka have become more targeted. General and administrative expenses aggregated $680,000 for the three months ended October 31, 2008 compared to $1,024,000 for the three months ended October 31, 2007. Professional fees, including accounting and legal fees have decreased from the prior year and travel related expenses have also decreased for the three months ended October 31, 2008 compared to the three months ended October 31, 2007.

Other Income (expense): Interest expense totaled $ 136,000 for the three months ended October 31, 2008 compared to expense of $64,000 for the three months ended October 31, 2007. The three months ended October 31, 2008 includes the accrual of $100,000 cumulative adjustment which the Company is contesting.

Impact of Inflation

Although management expects that our operations will be influenced by general economic conditions we do not believe that inflation has had a material effect on our results of operations.

Financial Liquidity and Capital Resources

Although our working capital position was initially improved as a result of our October 2008 Warrant Repricing Program and our December 2007 Private Placement of our preferred stock, our business continues to be effected by insufficient working capital. We will need to continue to carefully manage our working capital and our business decisions will continue to be influenced by our working capital requirements. Lack of liquidity continues to negatively affect our business and curtail the execution of our business plan.

We have experienced net losses and negative cash flows from operations and investing activities since our inception in 2003. Net losses for the six months ended October 31, 2008 and 2007 were $2,484,204 and $3,050,359, respectively. Cash used in operating activities for the six months ended October 31, 2008 and 2007 were $47,998 and $1,572,617, respectively. We have to date funded our operations predominantly through bank borrowings, loans from shareholders and investors, and proceeds from the sale of our common stock, preferred stock, and warrants. For the six months ended October 31, 2008 and 2007 net cash provided by financing activities totaled $646,287 and $591,939, respectively.

On October 27, 2008, in order to encourage holders of warrants which we issued in our January Financing (described below) to exercise their warrants, and enabling us to decrease the number of unexercised warrants and raise short-term working capital at low cost, the Company reduced the exercise price from $.50 to $0.20 per share of common stock for a period of 5 trading days, subject to adjustment in the event that the Company’s stock trades for $1.50 or higher (subject to adjustments for forward and reverse stock splits, recapitalizations, stock dividends, and the like after the date hereof) for ten (10) consecutive trading days through February 28, 2009 then the exercise price reverts to the exercise price of $.50 per share and the warrant holders must pay the Company the difference of $.30 per share, as part of this re-pricing program. Each of the investors who participated in the January Financing exercised all of the warrants issued in the private placement representing a total of 3,777,778 newly issued shares of common stock, resulting in proceeds to the Company of $755,556 less a due diligence fee paid of $70,693. We also agreed to reduce the conversion price of the preferred stock acquired by these investors in our December Financing (described below) from $0.50 per share of common stock to $0.35 per share. There are a total of 11,000 shares of preferred shares outstanding with a redemption value of $11,000,000 which if all the preferred stock was converted would result in the issuance of 31,428,571 shares of our common stock. One other investor, Greenwich Beverage Group LLC, who is controlled by a member of our board of directors, elected to exercise warrants for a total of 166,667 shares of common stock at $0.20 per share, which the Company reduced from $1.25, for an aggregate exercise price of $33,333.

The financing that we consummated in January 2007 (the “January Financing”) provided participating investors (the “January Investors”) rights to exchange the common stock they acquired for securities issued in subsequent financings which were consummated at a common stock equivalent of $2.00 per share or less. Under this provision, the January Investors have exchanged 4,444,445 shares of common stock for 8,000 shares of Preferred Stock. The 4,444,445 shares returned were accounted for as a reduction of Additional Paid in Capital and a reduction of Common Stock since the shares have been cancelled. Also in the January Financing, the January Investors acquired warrants to purchase 3,777,778 shares of our common stock at an exercise price of $3.00 per share (the “January Warrants”). These warrants were exercised at $.20 per share of common stock. We have issued an aggregate of 11,000 shares of our Series A Preferred Stock with a redemption value of $11,000,000, which under their original terms were convertible into our Common Stock at $50 per share, and now convertible at $.35 per share.

Each of our December Investors participated in the January Financing but not all of our January Investors participated in the December Financing.

The December Investors may allege that certain penalties are owed to them by the Company based on certain time requirements in the documentation relating to the December Financing. If such claim is successfully made, we may lack the liquidity to satisfy such claim.

From July 2007 through April 2008 the Company borrowed an aggregate of $522,303 from our CEO for working capital purposes. For the six months ended October 31, 2008 the Company borrowed an additional $123,3750 from our CEO for working capital purposes. The borrowings bear interest at 12% per annum. As of October 31, 2008, a total of $358,654 including interest has been repaid. For the six months ended October 31, 2008 and 2007 interest accrued on this loan aggregated $18,831 and $15,648 respectively and for the three months ended October 31, 2008 and 2007, $10,334 and $13,849, respectively. As of October 31, 2008 and April 30, 2008 amounts owed to our CEO on these loans aggregated $343,652 and $232,547, respectively, including accrued interest

In June 2006, we entered into a $10 million, three-year, asset-based revolving credit facility with a financial institution to be used for working capital purposes. Under this line, we may borrow 85% of eligible accounts receivable, as defined under the agreement. Interest on the line accrues at 1.5% above the prime rate based on a minimum daily balance of $1 million. Also, in June 8 2006, we entered into a secured purchase order financing facility with another financial institution. The amount we are able to borrow under these facilities will depend on our outstanding eligible accounts receivable, inventory and eligible purchase orders, respectively. Both of these facilities are secured by our assets. As of October 31, 2008 $202,360 and $0 was outstanding on our revolving credit and purchase order facilities, respectively. In December 2008 the Company was notified by the lender, BACC that the lender has calculated interest on the working capital line incorrectly since the inception of the line in June 2006. Although the Company intends to vigorously contest the amount have accrued $100,000 of interest for the six months ended October 31, 2008 which is the approximate amount of the indicated “shortfall”. BACC has agreed to defer payment of the “back” interest beginning February 2009 payable over a 5 month period. The Company is currently engaged in a negotiation with BACC to modify certain terms of its agreement, including, without limitation, the aggregate amount of availability under the line and the terms under which interest is calculated.

ROYALTIES/LICENSING AGREEMENTS

In November 2005, the Company entered into an eight-year license agreement for sales of Trump Super Premium Vodka. Under the agreement the Company is required to pay royalties on sales of the licensed product. The agreement provides for certain minimum royalty payments through November 2012 which if not satisfied could result in termination of the license. The Company is currently engaged in a negotiation with Trump Marks LLC to modify certain terms of its license agreement, including, without limitation, the deferral of certain minimum aggregate royalties and the payment of on-going minimum royalties.

Under our license agreement for Old Whiskey River, we are obligated to pay royalties of between $10 and $33 per case, depending on the size of the bottle.

Under our license agreement for Newman’s Own, we are obligated to pay royalties of $.95 per twelve bottle case.

Under our license agreement for Damaina Liqueur we are obligated to pay $3 per case.

Under our license agreement with Aguila Tequila we are obligated to pay $3 per case.

OTHER AGREEMENTS

In fiscal 2003 we entered into a consulting agreement with a company, Marvin Traub & Associates (“MTA”), owned 100% by Marvin Traub, a member of the Board of Directors. Under the agreement, MTA is being compensated at the rate of $100,000 per annum. As of October 31, 2008, we were indebted to MTA in the amount of $206,248.

In December 2002, we entered into a consulting agreement with Mr. Shep Gordon which provides for payment of $120,000 per year to Mr. Gordon, payable through June 2009. As of October 31, 2008, the aggregate amount owed to Mr. Gordon was $90,000. We have an informal understanding with Mr. Gordon pursuant to which he can convert all or a portion of the consulting fees which we owe to him into shares of our common stock at a conversion price negotiated from time to time.

Since we were founded in 2002, the implementation of our business plan has been negatively affected by insufficient working capital. Business judgments have been substantially affected by the availability of working capital. Although our working capital position and our cash balance was initially improved as a result of our October 2008 Warrant Repricing Program and our December and January, 2007 private placement of our common stock, preferred stock and warrants, our business continues to be effected by insufficient working capital. We will need to continue to carefully manage our working capital and our business decisions will continue to be influenced by our working capital requirements. Therefore, our short term business strategy will rely heavily on our cost efficient icon brand strategy and the resources available to us from our media and entertainment partners We will continue to focus on those of our products which we believe will provide the greatest return per dollar of investment with the expectation that as a result of increases in sales and the resulting improvement in our working capital position, we will be able to focus on those products for which market acceptance might require greater investments of time and resources. To that end, our short-term focus, for beer and spirits, will be on Trump Super Premium Vodka, Old Whiskey River Bourbon, Damiana, Aquila Tequila, and in association with our recent joint venture with music icon Dr. Dre, a super premium cognac and unique sparkling vodka and our recent joint venture with music icon Kid Rock, a domestic beer. For the non-alcoholic beverages Newman’s Own lightly sparkling fruit juice drinks and waters. In order for us to continue and grow our business, we will need additional financing which may take the form of equity or debt. There can be no assurance we will be able to secure the financing we require, and if we are unable to secure the financing we need, we may be unable to continue our operations. We anticipate that increased sales revenues will help to some extent, but we will need to obtain funds from equity or debt offerings, and/or from a new or expanded credit facility. In the event we are not able to increase our working capital, we will not be able to implement or may be required to delay all or part of our business plan, and our ability to attain profitable operations, generate positive cash flows from operating and investing activities and materially expand the business will be materially adversely affected.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We do participate in certain transactions which are settled in foreign currencies. Such transactions are short term in nature and any corresponding fluctuation in foreign exchange rates have not been material. We do not hold instruments that are sensitive to changes in interest rates or commodity prices. Therefore, we believe that we are not materially exposed to market risks resulting from fluctuations from such rates or prices.

Item 4. Controls and Procedures

Disclosure Controls and Procedures

We have adopted and maintain disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) that are designed to provide reasonable assurance that information required to be disclosed in our reports under the Exchange Act, is recorded, processed, summarized and reported within the time periods required under the SEC's rules and forms and that the information is gathered and communicated to our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), as appropriate, to allow for timely decisions regarding required disclosure.

Our Chief Executive Officer and our Chief Financial Officer evaluated the effectiveness of our disclosure controls and procedures as of October 31, 2008 as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of October 31, 2008, our Chief Executive Officer, who also is our principal executive officer, and our Chief Financial Officer, who is our principal financial officer, concluded that, as of such date, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be declared by us in reports that we file with or submit to the SEC is (1) recorded, processed, summarized, and reported within the periods specified in the SEC’s rules and forms and (2) accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, to allow timely decisions regarding required disclosure.

There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended October 31, 2008, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II OTHER INFORMATION

Item 1. Legal Proceedings

Item 1A. Risk Factors

There have been no material changes from the risk factors as previously disclosed in our Annual Report on Form 10-KSB for the year ended October 31, 2008.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On October 23, 2008 under an agreement with one of the Company’s consultants a warrant to purchase 54,000 shares of the Company’s common stock at exercise prices ranging from $0.19 to $2.12 per share.

On September 26, 2008 as a bonus for work performed, the Company granted its Chief Financial Officer warrants to purchase 300,000 shares of its common stock at an exercise price of $.50 per share. The warrants expire five years from the date of the agreement.

On August 28, 2008, as part of his consulting agreement, the Company agreed to issue a sales consultant warrants to purchase an additional 200,000 shares of the Company’s common stock at an exercise price of $0.50 per share. This issuance satisfies the Company’s requirements for the contract years ending August 2007 and 2008. Also, on August 28, 2008 the consultant and the Company agreed to convert $150,000 of past due consulting fees into 300,000 shares of common stock at $0.50 per share which was at a premium to the market price on date of grant.

On August 21, 2008 the Company agreed to issue the principals of a consulting company warrants to purchase 500,000 shares of the Company’s common stock at an exercise price of $0.50 per share. The warrants were issued to the principals for their role in the Company securing a strategic relationship. The warrants expire five years from the date of grant.

In July 2008 in connection with an extension of a licensing agreement for one of our brands the Company issued 100,000 shares of common stock and warrants to purchase an additional 300,000 shares of common stock to a charitable organization supported by one of the icons with whom we have a relationship. Company management has determined the value of such shares at the date of grant was $25,000. Under the terms of the warrant agreement 100,000 shares of common stock are exercisable September 1, 2009, 100,000 shares of common stock are exercisable September 1, 2010, and 100,000 shares of common stock are exercisable September 1, 2010. The exercise price of the warrants is $0.50 per share. The warrants expire five years from the date of the shares are exercisable.

In July 2008 in connection with an extension of a licensing agreement for one of our brands the Company issued 100,000 shares of common stock and warrants to purchase an additional 300,000 shares of common stock to a charitable organization supported by one of the icons with whom we have a relationship. Under the terms of the warrant agreement 100,000 shares of common stock are exercisable September 1, 2009, 100,000 shares of common stock are exercisable September 1, 2010, and 100,000 shares of common stock are exercisable September 1, 2010. The exercise price of the warrants is $0.50 per share. The warrants expire five years from the date of the shares are exercisable. Management has determined that the aggregate value of the warrants was $3,000.

In June 2008, 50,000 shares of our common stock and warrants to purchase an additional 150,000 shares or shares of our common stock was issued to one of the Company’s vendors as part of an agreement to sell their brand. The aggregate market value of the stock issued was $12,500 based on the market price on the date of grant. The exercise price of the warrants is $0.50 per share. The warrants expire five years from the date of the agreement. Management has determined that the aggregate value of the warrants was $1,700.

Item 3. Defaults Upon Senior Securities

None

Item 4. Submission of Matters to a Vote of Security Holders

None6

Item 5. Other Information

None

Item 6. Exhibits

31.1	Certification of J. Patrick Kenny, President and Chief Executive Officer

31.2	Certification of Jeffrey Daub, Chief Financial Officer

32.1	Certification of J. Patrick Kenny, President and Chief Executive Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2	Certification of Jeffrey Daub, Chief Financial Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

December 19, 2008

	DRINKS AMERICAS HOLDINGS, LTD.

	By:	/s/ J. Patrick Kenny
		J. Patrick Kenny President and Chief Executive Officer

	By:	/s/ Jeffrey Daub
		Jeffrey Daub Chief Financial Officer

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

Drinks Americas (DKAM) Inactive 10-Q2009 Q2 Quarterly report

Content analysis